MBP metabolic pharmaceuticals limited

Livett is the original developer of ACV1. Interesting that he...

  1. 182 Posts.
    Livett is the original developer of ACV1. Interesting that he lists some of the other companies working on conotoxins. We are not alone!!!
    http://grimwade.biochem.unimelb.edu.au/cone/index1.html
    All the research abstracts on the index page tell a story too:
    http://grimwade.biochem.unimelb.edu.au/cone/index1.html
    suggests there is a huge race on in the conotoxin field
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.